Venrock Adviser, LLC
NEW YORK, NY · CIK 1615982 · 13F filing filed 2023-05-15
SEC-registered investment adviser since 2014 · limited liability company
- Assets managed$4.5bn
- Staff11 · 11 in investment roles
- Main clients (by assets)Private funds 100%
- Private funds7 (1 hedge) · $4.5bn gross assets
- Form ADV · 2026-04-28SEC adviser record
- Legal entityVENROCK ADVISER, LLC (US)
- Kindhedge funds, private equity
- Others nearbyNew York, NY, Palo Alto, CA
As an employer
- Offices in1 country
- Private fundshedge 1, private equity 6
Where they work
Offices
From Form ADV: the main office and the other offices where it does advisory work (at most the 25 largest), with the people doing investment work at each. “About” is worked out: the firm's investment staff less its other offices. Each city links to the other managers there.
| City | People |
|---|---|
| New York, NY (main office)United States | about 11 |
| Palo Alto, CAUnited States |
Map: places from GeoNames (CC BY 4.0), outlines from Natural Earth.
$593.6m
reported value
-8.4% vs Q3 2022
28positions
70.6%in top 10
7 new
4 added
6 reduced
10 sold out
vs Q3 2022
Holdings, Q4 2022
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| VIRIDIAN THERAPEUTICS INC VRDN | $78.9m13.29% | Added +569.6k |
| ACLARIS THERAPEUTICS INC ACRS | $71.9m12.11% | Unchanged |
| AXSOME THERAPEUTICS INC AXSM | $51.7m8.71% | New |
| COGENT BIOSCIENCES INC COGT | $46.7m7.86% | Unchanged |
| TERNS PHARMACEUTICALS INC COM | $37.7m6.36% | Unchanged |
| GH RESEARCH PLC GHRS | $34.2m5.76% | Added +184.0k |
| CELCUITY INC CELC | $29.5m4.97% | New |
| DICE THERAPEUTICS INC COM | $25.6m4.30% | Added +54.0k |
| AEROVATE THERAPEUTICS INC COM | $21.9m3.69% | Reduced -86.1k |
| PLIANT THERAPEUTICS INC PLRX | $20.9m3.52% | Unchanged |
| KALVISTA PHARMACEUTICALS INC KALV | $19.7m3.32% | New |
| NOVAVAX INC NVAX | $19.3m3.26% | New |
| MERUS N V MRUS | $19.0m3.20% | New |
| CABALETTA BIO INC CABA | $17.5m2.95% | New |
| ANNEXON INC ANNX | $16.6m2.80% | Unchanged |
| VECTIVBIO HLDG AG ORD SHS | $16.2m2.72% | New |
| PROVENTION BIO INC PRVB | $11.8m1.99% | Unchanged |
| SAVARA INC SVRA | $9.8m1.66% | Added +1.8m |
| MILESTONE PHARMACEUTICALS IN MIST | $8.7m1.47% | Reduced -216.9k |
| LIANBIO LIANY | $7.9m1.32% | Reduced -585.3k |
| MARINUS PHARMACEUTICALS INC MRNS | $7.0m1.19% | Reduced -1.4m |
| TREVI THERAPEUTICS INC TRVI | $5.9m0.99% | Unchanged |
| FULCRUM THERAPEUTICS INC FULC | $3.3m0.55% | Reduced -752.7k |
| LYRA THERAPEUTICS INC LYRA | $2.9m0.49% | Unchanged |
| INOZYME PHARMA INC COM | $2.8m0.48% | Unchanged |
| ATYR PHARMA INC ATYR | $2.6m0.43% | Reduced -227.5k |
| AFFIMED N V COM | $1.8m0.30% | Unchanged |
| RALLYBIO CORP COM | $1.8m0.30% | Unchanged |
Sold out since Q3 2022
| Security | Value then |
|---|---|
| TRICIDA INC TCDA | $94.8m9.1m shares |
| RELMADA THERAPEUTICS INC RLMD | $56.2m1.5m shares |
| GOSSAMER BIO INC GOSS | $20.9m1.7m shares |
| INSTIL BIO INC | $19.9m4.1m shares |
| AKOUOS INC | $18.9m2.8m shares |
| VENTYX BIOSCIENCES INC VTYX | $7.3m207.9k shares |
| PROMETHEUS BIOSCIENCES INC | $7.2m121.7k shares |
| ALTIMMUNE INC ALT | $4.7m369.3k shares |
| IMMUNOCORE HLDGS PLC IMCR | $4.4m94.6k shares |
| CELLDEX THERAPEUTICS INC NEW CLDX | $2.1m75.0k shares |